The COMPASS study: A prospective, randomized, multi-center trial testing the impact of a clinic-based intervention informing patients of colorectal cancer screening options on screening completion

Joan M Griffin, Lila J Finney Rutten, Xuan Zhu, Ziding Feng, Charles R Rogers, Tracey L Marsh, John M Inadomi, Joan M Griffin, Lila J Finney Rutten, Xuan Zhu, Ziding Feng, Charles R Rogers, Tracey L Marsh, John M Inadomi

Abstract

Background: Colorectal cancer (CRC) screening is underutilized despite evidence that screening improves survival. Since healthcare provider recommendation is a strong predictor of CRC screening completion, providers are encouraged to engage eligible patients in collaborative decision-making that attends to patients' values, needs, and preferences for guideline-concordant screening modalities.

Methods: This three-arm randomized controlled trial is testing the effectiveness of an evidence-based video intervention informing patients of screening choices delivered in a clinic prior to a healthcare appointment. We hypothesize that participants randomized to watch a basic video describing CRC and screening in addition to an informed choice video showing the advantages and disadvantages of fecal immunochemical test (FIT), stool DNA FIT (s-DNA FIT), and colonoscopy (Arm 3) will exhibit a greater proportion of time adherent to CRC screening guidelines after 1, 3 and 6 years than those who only watch the basic video (Arm 2) or no video at all (Arm 1). Primary care and Obstetrician/Gynecology clinics across the United States are recruiting 5280 patients, half who have never been screened and half who previously screened but are currently not guideline adherent. Participants complete surveys prior to and following an index appointment to self-report personal, cognitive, and environmental factors potentially associated with screening. Proportion of time adherent to screening guidelines will be assessed using medical record data and supplemented with annual surveys self-reporting screening.

Conclusion: Results will provide evidence on the effectiveness of informational and motivational videos to encourage CRC screening that can be easily integrated into clinical practice.

Clinicaltrials: gov #NCT05246839.

Keywords: Behavior change theory; Clinical trial; Colonic neoplasms; Colorectal cancer screening; Early detection of screening; Early medical intervention.

Copyright © 2022 The Authors. Published by Elsevier Inc. All rights reserved.

Figures

Fig. 1.
Fig. 1.
COMPASS conceptual model.
Fig. 2.
Fig. 2.
COMPASS study timeline.

References

    1. American Cancer Society, Cancer Facts and Figures, 2022, American Cancer Society, Atlanta GA, 2022.
    1. U.S. Cancer Statistics Data Visualizations Tool, based on 2020 submission data (1999–2018), US Department of Health and Human Services, National Cancer Institute, Centers for Disease Control and Prevention, 2021. Accessed December 27, 2021, at, .
    1. Joseph D, King J, Dowling N, Thomas C, Richardson L, Vital signs: colorectal cancer screening test use — United States, 2018, MMWR Morb. Mortal. Wkly Rep 69 (2020) 253–259.
    1. Davidson KW, Barry MJ, Mangione CM, et al., Screening for colorectal cancer: US preventive services task force recommendation statement, Jama 325 (2021) 1965–1977.
    1. Healthy People 2030, U.S. Department of Health and HUman Services, 2020, Accessed December 27, 2021, at, .
    1. Achieving 80% Colorectal Cancer Screening Rates in Every Community, 80% in Every Community, at, .
    1. Finney Rutten LJ, Nelson DE, Meissner HI, Examination of population-wide trends in barriers to cancer screening from a diffusion of innovation perspective (1987–2000), Prev. Med 38 (2004) 258–268.
    1. Deroche CB, McDermott SW, Mann JR, Hardin JW, Colorectal cancer screening adherence in selected disabilities over 10 years, Am. J. Prev. Med 52 (2017) 735–741.
    1. Mazidimoradi A, Tiznobaik A, Salehiniya H, Impact of the COVID-19 pandemic on colorectal cancer screening: a systematic review, J. Gastrointest. Cancer (2021) 1–15.
    1. Harber I, Zeidan D, Aslam MN, Colorectal cancer screening: impact of COVID-19 pandemic and possible consequences, Life (Basel) 11 (2021).
    1. Rogers CR, Goodson P, Dietz LR, Okuyemi KS, Predictors of intention to obtain colorectal cancer screening among African American men in a state fair setting, Am. J. Mens Health 12 (2018) 851–862.
    1. Gregory TA, Wilson C, Duncan A, Turnbull D, Cole SR, Young G, Demographic, social cognitive and social ecological predictors of intention and participation in screening for colorectal cancer, BMC Public Health 11 (2011) 38.
    1. Power E, Van Jaarsveld CH, McCaffery K, Miles A, Atkin W, Wardle J, Understanding intentions and action in colorectal cancer screening, Ann. Behav. Med 35 (2008) 285–294.
    1. Vernon SW, Participation in colorectal cancer screening: a review, J. Natl. Cancer Inst 89 (1997) 1406–1422.
    1. Cokkinides VE, Chao A, Smith RA, Vernon SW, Thun MJ, Correlates of underutilization of colorectal cancer screening among U.S. adults, age 50 years and older, Prev. Med 36 (2003) 85–91.
    1. Zapka JG, Puleo E, Vickers-Lahti M, Luckmann R, Healthcare system factors and colorectal cancer screening, Am. J. Prev. Med 23 (2002) 28–35.
    1. Inadomi JM, Vijan S, Janz NK, et al., Adherence to colorectal cancer screening: a randomized clinical trial of competing strategies, Arch. Intern. Med 172 (2012) 575–582.
    1. Schroy PC 3rd, Emmons K, Peters E, et al., The impact of a novel computer-based decision aid on shared decision making for colorectal cancer screening: a randomized trial, Med. Decis. Mak 31 (2011) 93–107.
    1. Zhu X, Weiser E, Jacobson DJ, Griffin JM, Limburg PJ, Finney Rutten LJ, Patient preferences on general health and colorectal cancer screening decision-making: results from a national survey, Patient Educ. Couns 105 (4) (2021) 134–140.
    1. Wolf AMD, Fontham ETH, Church TR, et al., Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society, CA Cancer J. Clin 68 (2018) 250–281.
    1. Barry MJ, Edgman-Levitan S, Shared decision making–pinnacle of patient-centered care, N. Engl. J. Med 366 (2012) 780–781.
    1. Melson JE, Imperiale TF, Itzkowitz SH, et al., AGA white paper: roadmap for the future of colorectal cancer screening in the United States, Clin. Gastroenterol. Hepatol 18 (2020), 2667–78.e2.
    1. Volk RJ, Leal VB, Jacobs LE, et al., From guideline to practice: new shared decision-making tools for colorectal cancer screening from the American Cancer Society, CA Cancer J. Clin 68 (2018) 246–249.
    1. Singal AG, Gupta S, Skinner CS, et al., Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: a randomized clinical trial, Jama 318 (2017) 806–815.
    1. Wunderlich T, Cooper G, Divine G, et al., Inconsistencies in patient perceptions and observer ratings of shared decision making: the case of colorectal cancer screening, Patient Educ. Couns 80 (2010) 358–363.
    1. Rutten LJF, Parks P, Weiser E, Zhu X, Griffin JM, Limburg PJ, Healthcare Provider Perspectives on Lowering Colorectal Cancer Screening Initiation Age to 45 Years: Results From a Survey of Clinicians in the U.S. Cancer Control 27, 2020, 1073274820977112.
    1. Zhu X, Parks PD, Weiser E, Jacobson DJ, Limburg PJ, Rutten LJF, Barriers to utilization of three colorectal cancer screening options–data from a national survey, Prev. Med. Rep 24 (2021), 101508.
    1. Partin MR, Noorbaloochi S, Grill J, et al., The interrelationships between and contributions of background, cognitive, and environmental factors to colorectal cancer screening adherence, Cancer Causes Control 21 (2010) 1357–1368.
    1. Burgess DJ, Van Ryn M, Grill J, et al., Presence and correlates of racial disparities in adherence to colorectal cancer screening guidelines, J. Gen. Intern. Med 26 (2011) 251–258.
    1. Bandura A, Social Foundations of Thought and Action: A Social Cognitive Theory, Prentice-Hall, Inc, Englewood Cliffs, NJ, US, 1986.
    1. Ajzen I, The theory of planned behavior, Organ. Behav. Hum. Decis. Process 50 (1991) 179–211.
    1. Wolf AM, Fontham ET, Church TR, et al., Colorectal cancer screening for average-risk adults: 2018 guideline update from the American Cancer Society, CA Cancer J. Clin 68 (2018) 250–281.
    1. Bandura A, Social cognitive theory of mass communication, Media Psychol. 3 (2001) 265–299.
    1. Chaiken S, Heuristic versus systematic information processing and the use of source versus message cues in persuasion, J. Pers. Soc. Psychol 39 (1980) 752.
    1. Cialdini RB, Influence: The Psychology of Persuasion, revised edition, William Morrow, New York, 2006.
    1. Petty RE, Cacioppo JT, The Elaboration Likelihood Model of Persuasion. Communication and persuasion, Springer, 1986, pp. 1–24.
    1. Chubak J, Anderson ML, Cook AJ, Murphy CC, Jackson ML, Green BB, Methodologic considerations in calculating and analyzing proportion of time covered as a measure of longitudinal cancer screening adherence, Cancer Epidemiol. Biomark. Prev 29 (2020) 1549–1556.
    1. Green BB, Anderson ML, Cook AJ, et al., A centralized mailed program with stepped increases of support increases time in compliance with colorectal cancer screening guidelines over 5 years: a randomized trial, Cancer 123 (2017) 4472–4480.
    1. Feng Z, Grizzle JE, Correlated binomial variates: properties of estimator of intraclass correlation and its effect on sample size calculation, Stat. Med 11 (1992) 1607–1614.
    1. Feng Z, McLerran D, Grizzle J, A comparison of statistical methods for clustered data analysis with Gaussian error, Stat. Med 15 (1996) 1793–1806.
    1. Volk RJ, Linder SK, Lopez-Olivo MA, et al., Patient decision aids for colorectal cancer screening: a systematic review and meta-analysis, Am. J. Prev. Med 51 (2016) 779–791.
    1. Zapka JG, Lemon SC, Puleo E, Estabrook B, Luckmann R, Erban S, Patient education for colon cancer screening: a randomized trial of a video mailed before a physical examination, Ann. Intern. Med 141 (2004) 683–692.
    1. Mojica CM, Gunn R, Pham R, et al., An observational study of workflows to support fecal testing for colorectal cancer screening in primary care practices serving Medicaid enrollees, BMC Cancer 22 (2022) 106.
    1. Davis MM, Freeman M, Shannon J, et al., A systematic review of clinic and community intervention to increase fecal testing for colorectal cancer in rural and low-income populations in the United States–How, what and when? BMC Cancer 18 (2018) 1–16.

Source: PubMed

스폰서 및 공동 작업자

건강 상태

약물 개입

3
구독하다